GGrantIndex
← Leaderboards

Katherine Arnold Hutcheson

University Of Tx Md Anderson Can Ctr

$5,107,957
Attributed
$6,255,655
Total exposure
9
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $7.3M · FY201525
$10M$7.5M$5M$2.5M$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$13,502,072 · 11

By mechanism

P01$9,088,928 · 5
R01$3,488,537 · 3
R21$764,607 · 2
R03$160,000 · 1

Most similar at University Of Tx Md Anderson Can Ctr

Same institution · by research overlap

Others in their field

Top investigators on “Quality Of Life

Research focus

Quality Of LifeCancer SurvivorMalignant NeoplasmsDoseDeglutitionToxic EffectHead And Neck CancerRadiation TherapyResearch PersonnelInjuryDeglutition DisordersCancer SurvivorshipPneumoniaSurvivorsPublishingImageReportingStructureHead And Neck StructureRadiationChronicClinical TrialsMuscleDiagnosis

Grant awards (23)

InHANCE: Imaging Innovation for Head And Neck Cancer Evaluation & Treatment Delivery$2,392,505
P01 · FY2025 · CA
OPC SURVIVOR: Optimizing OroPharyngeal Cancer SURVIVORship$2,341,478
P01 · FY2025 · CA · contact PI
Harvard MD Anderson Collaborative to Reduce LyMphatic MOrbidity in Head and Neck Cancer with Artificial Intelligence (HARMONiC-AI)$732,513
R01 · FY2025 · DE
Dissemination and implementation of DIGEST™ as an evidence-based measurement tool for dysphagia in cancer$635,890
R01 · FY2025 · CA · contact PI
Project 2: InHANCE: Radiation Associated Dysphagia$494,222
P01 · FY2025 · CA · contact PI
Project 2: OPC-NERVE$423,429
P01 · FY2025 · CA · contact PI
Core A: Administrative$212,612
P01 · FY2025 · CA · contact PI
InHANCE: Imaging Innovation for Head And Neck Cancer Evaluation & Treatment Delivery$64,622
P01 · FY2025 · CA
OPC SURVIVOR: Optimizing OroPharyngeal Cancer SURVIVORship$2,447,812
P01 · FY2024 · CA · contact PI
Dissemination and implementation of DIGEST™ as an evidence-based measurement tool for dysphagia in cancer$611,768
R01 · FY2024 · CA · contact PI
Project 2: OPC-NERVE$492,852
P01 · FY2024 · CA · contact PI
Core A: Administrative$219,396
P01 · FY2024 · CA · contact PI
Hypoglossal neuropathy in the pathogenesis of radiation associated dysphagia (hRAD)$196,648
R21 · FY2024 · CA · contact PI
Dissemination and implementation of DIGEST™ as an evidence-based measurement tool for dysphagia in cancer$698,767
R01 · FY2023 · CA · contact PI
Hypoglossal neuropathy in the pathogenesis of radiation associated dysphagia (hRAD)$190,380
R21 · FY2023 · CA · contact PI
imaging Radiation-Associated Dysphagia (iRAD)$217,667
R01 · FY2019 · CA
Manual Therapy for Fibrosis-related Late Effect Dysphagia in Head and Neck Cancer Survivors: The MANTLE Trial$168,779
R21 · FY2019 · CA · contact PI
imaging Radiation-Associated Dysphagia (iRAD)$68,332
R01 · FY2019 · CA
imaging Radiation-Associated Dysphagia (iRAD)$261,800
R01 · FY2018 · CA
Manual Therapy for Fibrosis-related Late Effect Dysphagia in Head and Neck Cancer Survivors: The MANTLE Trial$208,800
R21 · FY2018 · CA · contact PI
imaging Radiation-Associated Dysphagia (iRAD)$261,800
R01 · FY2017 · CA
Lingual Strength & Dysphagia after Oropharynx Cancer: Proton vs. Photon Radiation$80,000
R03 · FY2016 · CA · contact PI
Lingual Strength & Dysphagia after Oropharynx Cancer: Proton vs. Photon Radiation$80,000
R03 · FY2015 · CA · contact PI